Limitless X Holdings Inc. Files Q1 2024 10-Q

Ticker: LIMX · Form: 10-Q · Filed: May 20, 2024 · CIK: 1803977

Limitless X Holdings INC. 10-Q Filing Summary
FieldDetail
CompanyLimitless X Holdings INC. (LIMX)
Form Type10-Q
Filed DateMay 20, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, company-information, financial-reporting

TL;DR

Limitless X Holdings (formerly BIO LAB NATURALS) filed its Q1 2024 10-Q. Beverly Hills HQ.

AI Summary

Limitless X Holdings Inc. filed its 10-Q for the period ending March 31, 2024. The company, formerly BIO LAB NATURALS, INC., is incorporated in Delaware and operates in the amusement and recreation sector. Its principal executive offices are located in Beverly Hills, California.

Why It Matters

This filing provides a quarterly update on Limitless X Holdings Inc.'s financial performance and operational status, crucial for investors and stakeholders to assess the company's trajectory.

Risk Assessment

Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new information presented.

Key Players & Entities

FAQ

What was Limitless X Holdings Inc.'s former name?

Limitless X Holdings Inc.'s former name was BIO LAB NATURALS, INC., with the name change occurring on February 19, 2020.

What is the primary business address of Limitless X Holdings Inc.?

The primary business address is 9454 WILSHIRE BLVD., #300, BEVERLY HILLS, CA 90212.

What is the Standard Industrial Classification (SIC) code for Limitless X Holdings Inc.?

The SIC code is 7990, categorized under SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION.

When was the current 10-Q filing submitted?

The filing was submitted on May 20, 2024.

What is the fiscal year end for Limitless X Holdings Inc.?

The fiscal year end for Limitless X Holdings Inc. is December 31.

Filing Stats: 4,476 words · 18 min read · ~15 pages · Grade level 15.1 · Accepted 2024-05-20 15:23:48

Key Financial Figures

Filing Documents

Financial Statements

Financial Statements 1 Unaudited Condensed Consolidated Balance Sheets 1 Unaudited Condensed Consolidated Statements of Operations 2 Unaudited Condensed Consolidated Statement of Changes in Stockholders' Deficit 3 Unaudited Condensed Consolidated Statements of Cash Flows 5 Notes to the Unaudited Condensed Consolidated Financial Statements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 21 Item 4.

Controls and Procedures

Controls and Procedures 21

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 22 Item 1A.

Risk Factors

Risk Factors 22 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22 Item 3. Defaults Upon Senior Securities 22 Item 4. Mine Safety Disclosures 22 Item 5. Other Information 22 Item 6. Exhibits 22

Signatures

Signatures 23 i LIMITLESS X HOLDINGS INC. PART I – FINANCIAL INFORMATION Item 1. Financial Statements LIMITLESS X HOLDINGS INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Unaudited) March 31, December 31, 2024 2023 ASSETS Current Assets: Cash $ 22,885 $ 116,100 Accounts receivables, net 185,079 116,888 Inventories 74,367 21,857 Prepaid expenses 12,500 12,500 Due from related parties 27,593 - Total current assets 322,424 267,345 Non-Current Assets: Property and equipment, net 28,292 29,410 Other assets 7,235 10,985 Total non-current assets 35,527 40,395 Total assets $ 357,951 $ 307,740 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable and accrued expenses $ 7,814,543 $ 7,318,230 Accrued interest 632,111 531,149 Royalty payable 34,567 - Refunds payable 8,599 41,509 Chargebacks payable 10,749 20,755 Note payable 35,000 35,000 Notes payable to shareholder 5,152,028 5,152,028 Notes payable to related parties 619,428 80,000 Notes payable 619,428 80,000 Total current liabilities 14,307,025 13,178,671 Total liabilities 14,307,025 13,178,671 Commitments and contingencies - - Stockholders' deficit Preferred Stock A - $ 0.0001 par value; 30,000,000 authorized shares; 500,000 shares issued and outstanding 50 50 Preferred Stock B - $ 0.0001 par value; 30,000,000 authorized shares; 10,349,097 shares issued and outstanding 1,035 1,035 Preferred Stock Value 1,035 1,035 Common Stock- $ 0.0001 par value; 300,000,000 authorized shares; 3,977,497 issued and outstanding 399 399 Additional paid-in-capital 13,265,500 13,265,500 Retained earnings ( 27,216,058 ) ( 26,137,915 ) Total stockholders' deficit ( 13,949,074 ) ( 12,870,931 ) Total liabilities and stockholders' deficit $ 357,951 $ 307,740 The accompanying notes are an integral part of these unaudited condensed consolidated financial

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing